FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,704 | -97.1% | 19,200 | -86.2% | 0.00% | -100.0% |
| Q4 2022 | $1,402,510 | -26.2% | 139,000 | +63.8% | 0.01% | -25.0% |
| Q3 2022 | $1,901,000 | -23.7% | 84,856 | -15.6% | 0.02% | -33.3% |
| Q2 2022 | $2,493,000 | +564.8% | 100,592 | +2343.3% | 0.02% | +380.0% |
| Q4 2020 | $375,000 | +3.0% | 4,117 | -54.8% | 0.01% | -28.6% |
| Q3 2020 | $364,000 | -75.7% | 9,113 | -90.5% | 0.01% | -84.1% |
| Q3 2019 | $1,496,000 | +547.6% | 96,400 | +748.2% | 0.04% | +450.0% |
| Q2 2019 | $231,000 | -87.8% | 11,365 | -90.2% | 0.01% | -90.5% |
| Q3 2018 | $1,891,000 | – | 116,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |